Publication | Closed Access

Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial

5-Year AnalysisNeuro-oncologyOncologyRadiation TherapyAdjuvant TemozolomideHigh-grade GliomasEortc-ncic TrialCancer TreatmentRadiation OncologyMedicineGlioma